Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Otolaryngol ; 45(3): 394-401, 2020 05.
Article in English | MEDLINE | ID: mdl-32058675

ABSTRACT

OBJECTIVES: To evaluate the clinical efficacy of a high-efficiency air purifier in patients with allergic rhinitis. DESIGN: We conducted a randomised, double-blind, clinical controlled trial with active and inactive versions of an air purifier. Our study included patients with allergic rhinitis who were sensitive to Artemisia pollen and treatment of the indoor environment using air filtration at night. We evaluated the clinical efficacy of indoor air filtration during the Artemisia pollen scattering season in Yulin City in Shanxi Province, China. SETTING: The First Hospital of Yulin (Yulin City, Shanxi Province, China). PARTICIPANTS: A total of 90 patients with allergic rhinitis who were sensitive to allergens of Artemisia pollen were randomly assigned to one of two groups in equal numbers. MAIN OUTCOME MEASURES: The primary outcome measure was the difference in visual analogue scale scores from baseline. Secondary outcomes were changes from baseline in nasal symptoms, allergy symptom scores, responses to the Rhinoconjunctivitis Quality of Life Questionnaire, Epworth Sleepiness Scale scores and tolerability scores for the air purifier. RESULTS: Based on the allergy symptom score, we found significant differences in rhinitis symptoms between the groups who used the active versus the inactive air purifier. CONCLUSIONS: The results of our investigation demonstrated the health benefits of particle filtration.


Subject(s)
Air Filters , Artemisia , Pollen/adverse effects , Rhinitis, Allergic/etiology , Rhinitis, Allergic/therapy , Adult , Air Pollution, Indoor , Double-Blind Method , Female , Humans , Male , Middle Aged , Rhinitis, Allergic/diagnosis , Treatment Outcome
2.
BMC Public Health ; 18(1): 841, 2018 07 06.
Article in English | MEDLINE | ID: mdl-29976165

ABSTRACT

BACKGROUND: Allergic rhinitis (AR) is a worldwide health problem. Allergen avoidance is strongly recommended for AR patients. Air purification can reduce concentrations of particles in indoor air, including those of allergens. Air purifiers have been recommended by clinicians for AR patients, but few studies have focused on the removal of airborne allergens from home environments. Such studies have been limited by a lack of blinding, small samples, or a failure to measure allergen levels, disease activity, or a combination of these factors. This study investigates the efficacy of a high-efficiency air purifier in reducing disease activity in the homes of AR patients sensitive to the allergens produced by Artemisia (mugwort) pollen. METHODS: This is a randomized, double-blind, clinical controlled trial that will test active and inactive versions of an air purifier (Atmosphere®; Amway China). Sixty AR patients sensitive to the allergens produced by Artemisia pollen will be assigned randomly to two groups of equal numbers. All patients will undergo a 4-week treatment period and a 4-week observation period. Evaluation will be conducted at baseline (day 0) and on days 7, 14, 21, 28, and 56. The primary outcome measure will be the difference in visual analog scale scores from baseline. Secondary outcomes will be changes from baseline in nasal symptoms, allergy symptom scores, responses to the Rhinoconjunctivitis Quality of Life Questionnaire, Epworth Sleepiness Scale scores, and tolerability scores for the air purifier. Side effects of treatment will be recorded. DISCUSSION: Reducing exposure to allergens can reduce the risk of conditions such as AR. We hypothesise that AR patients sensitive to the allergens produced by Artemisia pollen will not suffer symptoms in a pollen-free environment. AR patients can remove pollen from their homes using air purifiers, decreasing the risk of symptoms. We expect that our study results will provide reliable evidence for determining the effects of air-purification therapy. TRIAL REGISTRATION: ChiCTR-INR-17012481 . (Retrospectively registered 26 August 2017).


Subject(s)
Air Filters , Air Pollution, Indoor/prevention & control , Allergens/adverse effects , Artemisia/adverse effects , Pollen/adverse effects , Rhinitis, Allergic/prevention & control , Allergens/analysis , China , Clinical Protocols , Double-Blind Method , Humans , Rhinitis, Allergic/etiology
3.
J Air Waste Manag Assoc ; 57(1): 94-101, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17269234

ABSTRACT

The investigation of the photocatalytic oxidation (PCO) of multicomponent volatile organic compounds (VOCs) is very important to the application of PCO technology, because there is seldom a single VOC component in indoor air. In this paper, the characteristics of binary indoor VOCs, toluene and benzene, were experimentally studied using a mass transfer based method that we developed. The concentration ranges for toluene and benzene were 4.48-27.4 mg/m3 and 1.82-4.08 mg/m3, respectively. We found the following: (1) the PCO of each individual contaminant studied obeys the unimolecular form of the Langmuir-Hinshelwood (L-H) rate form; (2) the PCO of the binary contaminants follow the competitive adsorption L-H rate form; (3) the reaction-coefficient for PCO of individual contaminants differs from that in the competitive adsorption L-H rate form; and (4) the component impact factor of A to B, put forward in this paper, is a useful parameter describing the influence of A on the reaction coefficient of B, and it was found that the impact factor of toluene (a chemically active component) on benzene (a chemically stable component) is high, and the impact factor of benzene on toluene is low.


Subject(s)
Benzene/chemistry , Toluene/chemistry , Algorithms , Catalysis , Chemical Phenomena , Chemistry, Physical , Kinetics , Oxidation-Reduction , Photochemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...